Financials

News Ideas Technicals Forecast

1733 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to APEX BIOTECHNOLOGY CORP operating, investing, and financing activities

1733 free cash flow for Q4 23 is 105.76 M TWD. For 2023, 1733 free cash flow was 244.27 M TWD and operating cash flow was 266.18 M TWD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—